Benchmark Botanics Stock Probability of Future Pink Sheet Price Finishing Over 0

BHHKF Stock  USD 0  0.00  0.00%   
Benchmark Botanics' future price is the expected price of Benchmark Botanics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Benchmark Botanics performance during a given time horizon utilizing its historical volatility. Check out Benchmark Botanics Backtesting, Benchmark Botanics Valuation, Benchmark Botanics Correlation, Benchmark Botanics Hype Analysis, Benchmark Botanics Volatility, Benchmark Botanics History as well as Benchmark Botanics Performance.
  
Please specify Benchmark Botanics' target price for which you would like Benchmark Botanics odds to be computed.

Benchmark Botanics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Benchmark Botanics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Benchmark Botanics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Benchmark Botanics generated a negative expected return over the last 90 days
Benchmark Botanics has some characteristics of a very speculative penny stock
Benchmark Botanics has a very high chance of going through financial distress in the upcoming years
Benchmark Botanics has accumulated 8.08 M in total debt with debt to equity ratio (D/E) of 1.5, which is about average as compared to similar companies. Benchmark Botanics has a current ratio of 0.13, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Benchmark Botanics until it has trouble settling it off, either with new capital or with free cash flow. So, Benchmark Botanics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Benchmark Botanics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Benchmark to invest in growth at high rates of return. When we think about Benchmark Botanics' use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 1.01 M. Net Loss for the year was (10.06 M) with loss before overhead, payroll, taxes, and interest of (62.33 K).
Benchmark Botanics has accumulated about 273.03 K in cash with (2.73 M) of positive cash flow from operations.

Benchmark Botanics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Benchmark Pink Sheet often depends not only on the future outlook of the current and potential Benchmark Botanics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Benchmark Botanics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding20.4 M

Benchmark Botanics Technical Analysis

Benchmark Botanics' future price can be derived by breaking down and analyzing its technical indicators over time. Benchmark Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Benchmark Botanics. In general, you should focus on analyzing Benchmark Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Benchmark Botanics Predictive Forecast Models

Benchmark Botanics' time-series forecasting models is one of many Benchmark Botanics' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Benchmark Botanics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Benchmark Botanics

Checking the ongoing alerts about Benchmark Botanics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Benchmark Botanics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Benchmark Botanics generated a negative expected return over the last 90 days
Benchmark Botanics has some characteristics of a very speculative penny stock
Benchmark Botanics has a very high chance of going through financial distress in the upcoming years
Benchmark Botanics has accumulated 8.08 M in total debt with debt to equity ratio (D/E) of 1.5, which is about average as compared to similar companies. Benchmark Botanics has a current ratio of 0.13, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Benchmark Botanics until it has trouble settling it off, either with new capital or with free cash flow. So, Benchmark Botanics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Benchmark Botanics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Benchmark to invest in growth at high rates of return. When we think about Benchmark Botanics' use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 1.01 M. Net Loss for the year was (10.06 M) with loss before overhead, payroll, taxes, and interest of (62.33 K).
Benchmark Botanics has accumulated about 273.03 K in cash with (2.73 M) of positive cash flow from operations.

Other Information on Investing in Benchmark Pink Sheet

Benchmark Botanics financial ratios help investors to determine whether Benchmark Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Benchmark with respect to the benefits of owning Benchmark Botanics security.